Bryan, Garnier & Co acts as Sole Financial Advisor to Enapter AG on a €20m strategic investment from Johnson Matthey

Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on GeNeuro EUR 7.7 million Follow-On Offering

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Avantium’s Euronext Amsterdam EUR 45m Publicly Marketed Follow-On Offering

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Aelis Farma’s Euronext Paris EUR 25m Initial Public Offering

Bryan, Garnier & Co is proud to act as Joint Bookrunner to Cell Impact on its SEK 349m Rights Issue

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner to Nicox on its EUR 15 million Follow-on Offering of shares and warrants

Bryan, Garnier & Co acts as Lead Joint Bookrunner to leading German Specialty Pharmaceuticals provider Medios AG on its EUR 93 million Follow-on Offering

Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to leading global IoT satellite operator Astrocast on its private placement and subsequent direct listing on Euronext Growth, securing a total of CHF 45 million for the company

Bryan, Garnier & Co acts as Sole Financial Advisor to Quilvest Capital Partners and the Management of Eudonet, a European vertical CRM software provider, on the sale of the Company to Montagu Private Equity

Bryan, Garnier & Co acts as Sole Global Coordinator and Joint Bookrunner on Enapter Follow-On Offering of EUR 30m